
Understanding the 2026 Medicare Physician Fee Schedule Final Rule
This article outlines important payment and policy changes that will shape reimbursement and practice operations for allergists in the coming year.

Adhering to USP 797 standards for in-office extract preparation
Compounding guidelines ensure patient safety by minimizing contamination, incorrect dosing, or other errors during sterile preparation.

Defend the allergy specialty
Our need to defend the allergy specialty is critical! These issues threaten our practices, specialty, and livelihoods.

Know the difference between build-up and dilution of allergy extracts
All seven MACs have now agreed in writing to cover the build-up phase of allergy extract preparation and administration.

CMS lifts temporary claims hold after series of confusing updates
Practices in areas with a work Geographic Practice Cost Indices (GPCI) factor less than 1.0 will have lower Medicare reimbursements.

Claims hold is impacting multiple services
CMS issued updated instructions clarifying that payments for select claims affected by expired legislative Medicare coverage policies should be held.

College seeks clarification on Cigna downcoding pause
We continue to encourage physicians and medical groups to voice their concerns until Cigna’s the policy is formally withdrawn.

Advocacy Council responds to the Proposed 2026 Medicare Physician Fee Schedule
The College’s Advocacy Council submitted formal comments to CMS on the 2026 Medicare Physician Fee Schedule proposed rule.

ACAAI Town Hall meeting – Learn strategies to benefit your practice
Get information on legislation that might affect your practice, advocacy issues, College resources and reasons to engage with your local/state societies.

Congress reintroduces the EPIPEN Act
The College’s Advocacy Council strongly believes that this bill, if passed, would ensure easier access to epinephrine for allergy patients.






